InvestorsHub Logo
Followers 44
Posts 864
Boards Moderated 0
Alias Born 03/08/2014

Re: sukus post# 218131

Thursday, 03/14/2019 4:30:34 AM

Thursday, March 14, 2019 4:30:34 AM

Post# of 701832
OK Sukus, here is some enthusiasm and encouragement.


TOP LINE:

PFS delta is 9 months

Tx vs crossovers and non vs non-crossovers deltas: 12 and 18 months respectively

OS36 Tx survival is 37%; OS60 Tx is 28%

Especially good results in M+ and MES which cover about 60% of all ndGBM

P=0.0000000000000000001 and HR is 0.13

Trial has unprecedented success in all areas.

After these results revealed, pandemonium breaks out and share price spikes to $125. Bidding war among major BPs and Merck wins with a bid of $523.43 per share. LP refuses bid and wants to wait for FDA approval.

FDA broad approval in three months. Share price spikes to $1,003 per share. Bidding war resumes and big P consortium offers buyout at $3,356.73 per share. LP accepts. Complete date is February, 2020.

AF reveals he was long all along and accumulated 10 million shares.

How's that for enthusiasm? LOL.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News